Clinical trial · Interventional
SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): lagging inclusions
Summary
Brief summary (as posted)
The goal of this single blind placebo-controlled intervention study is to examine the impact of a supervised training program on disease-related quality of life and physical fitness in patient with advanced prostate cancer compared to usual care. The main question\[s\] it aims to answer are: * What is the impact of exercise on quality of life * What is the impact of exercise on physical fitness Participants will have an individual training program with supervised training by physiotherapists. Researchers will compare with usual care to see if advice about exercise has significant less effect than an supervised training program.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastasis | — | UNRESOLVED | — |
| Prostatic Neoplasms | Prostate Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Physiotherapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- intervention
- description
- supervised training program for twelve weeks + usual care + advice about exercise
- interventionNames
- Other: Physiotherapy
- type
- NO_INTERVENTION
- label
- usual care
- description
- usual care + advice about exercise
Primary outcomes (4)
- measure
- change of quality of life assessed with EPIC26 (0-100 points)
- timeFrame
- 6 months
- description
- To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care. The following questionnaire is used: Expanded Prostate Cancer Index Composite (EPIC26). With higher scores representing better disease-related quality of life.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Signed informed consent * Age \> 18 years old * Able to read and complete questionnaires in Dutch * Proven histologically and /or radiologically metastatic prostate cancer (TxNxM1) Exclusion Criteria: * Other cancers * Clinicians' judgement * Age \>80 years old or not able to walk 400m * Structural exercise (moderate-intensity exercise more than 150 minutes a week) during the past 3 months * Musculoskeletal, cardiovascular, or neurological disorders that could inhibit them from exercising * Spinal cord compression, history of pathological fractures
References
Publications (0)
Data not yet available